Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > whoever is buying

<< Previous

Bullboard Posts

Next >>

Comment by dooneryon Oct 25, 2022 2:14pm

160 Views

Post# 35047437

RE:whoever is buying

biorun,,you are for sure correct in your post,,may i add,if the IDIOTS ,who are selling,STOP, our stock will go back up.JUST STOP SELLING,!!!!Think ABOUT THIS PEOPLE.I you dont sell ,,the stock will go back up.So,,,stot selling now,pleaseGLTA

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch